Financhill
Back

Syros Pharmaceuticals Quote, Financials, Valuation and Earnings

Syros Pharmaceuticals Price Quote

$2.01
+0.01 (+0.5%)
(Updated: September 18, 2024 at 6:55 PM ET)

Syros Pharmaceuticals Key Stats

Sell
38
Syros Pharmaceuticals (SYRS) is a Sell

Day range:
$1.93 - $2.13
52-week range:
$1.43 - $8.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.83
P/B ratio:
0%

Volume:
386.4K
Avg. volume:
531.8K
1-year change:
-49.11%
Market cap:
$53.6M
Revenue:
$9.9M
EPS:
$-4.34

How Much Does Syros Pharmaceuticals Make?

Data Unavailable

Is Syros Pharmaceuticals Growing As A Company?

Data Unavailable

Syros Pharmaceuticals Stock Price Performance

What Is Syros Pharmaceuticals 52-Week High & Low?

Syros Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Syros Pharmaceuticals?

Is Syros Pharmaceuticals Cash Flow Positive?

  • What Is SYRS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$111.2M
  • What Is Syros Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $43.2M
  • What Is Syros Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $30.6M

Syros Pharmaceuticals Return On Invested Capital

Data Unavailable

Syros Pharmaceuticals Earnings Date & Stock Price

Syros Pharmaceuticals Competitors

Syros Pharmaceuticals Dividend Yield

Syros Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 89.33%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.75
Upside from Last Price: 337.5%

Major Shareholders

  • How many SYRS shares are owned by institutional investors?
    24.6M SYRS shares are owned by institutional investors
  • How many SYRS shares are owned by insiders?
    698.5K SYRS shares are owned by insiders